−63.36 M EUR
0.00 EUR
40.34 M
About ACHILLES THERAP.SP.ADS/1
Sector
Industry
CEO
Iraj Ali
Website
Headquarters
Altrincham
Founded
2020
FIGI
BBG00ZXX35P1
Achilles Therapeutics Plc is a biopharmaceutical company engaged in developing transformative precision T-cell therapies to treat multiple types of solid tumors. It focuses on researching, developing and commercializing potentially novel cancer immunotherapies targeting clonal neoantigens. The company was founded by Karl Peggs, Sergio Quezada, Mark Lowdell and Charles Swanton in November 2020 and is headquartered in London, the United Kingdom.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.